文献速递血液净化与透析慢性肾脏病

透析前血管通路放置与透析起始时导管使用

Predialysis Vascular Access Placement and Catheter Use at Hemodialysis Initiation.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-10-16

本研究纳入380例晚期CKD患者,比较透析前放置AV内瘘或AV移植物的结局。当eGFR<15 ml/min per 1.73 m²时,AV移植物组无导管起始透析的比例高于AV内瘘组,且后续 Interventions 更少。

要点

  • eGFR<10时,AV移植物组无导管起始透析88% vs AV内瘘组43%(OR 9.10)。
  • eGFR 10-14时,AV移植物组无导管起始透析88% vs AV内瘘组54%(OR 6.05)。
  • AV内瘘组血管成形术、手术翻修、二次通路放置和导管插入均多于AV移植物组。

核心结论

  • 在eGFR<15 ml/min per 1.73 m²时行血管通路手术的CKD患者中,放置AV移植物比AV内瘘更可能无导管起始透析。

研究设计与样本

  • 单中心研究,纳入380例透析前放置AV内瘘(286例)或AV移植物(94例)的患者,平均年龄59±14岁,73%为黑人,51%为男性。

主要发现

  • eGFR<10、10-14、≥15 ml/min per 1.73 m²的患者分别有87例(23%)、179例(47%)、114例(30%)。
  • 从通路手术到透析起始的中位时间分别为69天(eGFR<10)、156天(eGFR 10-14)、429天(eGFR≥15)(P<0.001)。
  • 78%(298例)的患者在通路手术后2年内起始透析。
  • eGFR<10时,AV移植物组无导管起始透析88% vs AV内瘘组43%(OR 9.10,95%CI 2.74-26.4)。
  • eGFR 10-14时,AV移植物组无导管起始透析88% vs AV内瘘组54%(OR 6.05,95%CI 2.35-15.0);eGFR≥15时,AV移植物组90% vs AV内瘘组75%(OR 3.00,95%CI 0.48-34.9)。

关键数值与推荐

  • AV内瘘组血管成形术11% vs AV移植物组0%(P<0.001)。
  • AV内瘘组手术通路翻修26% vs AV移植物组8%(P<0.001)。
  • AV内瘘组二次通路放置16% vs AV移植物组6%(P=0.02)。
  • AV内瘘组导管插入32% vs AV移植物组11%(P<0.001)。

临床怎么用

  • 对于eGFR<15 ml/min per 1.73 m²的CKD患者,透析前放置AV移植物可能降低起始透析时导管使用。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines encourage placement of an arteriovenous (AV) fistula in patients with advanced CKD to avoid initiation of hemodialysis with a central venous catheter. However, the relative merits of predialysis placement of an AV fistula or graft have been poorly studied. METHODS: This study included 380 patients (mean age 59±14 years, 73% Black patients, 51% male) from a large academic medical center who underwent predialysis placement of an AV fistula (286) or AV graft (94). The study quantified three end points: time from access placement to initiation of dialysis, likelihood of starting hemodialysis without a catheter, and number of vascular access procedures before dialysis initiation. RESULTS: The eGFR at access surgery was <10, 10-14, and ≥15 ml/min per 1.73 m 2 in 87 (23%), 179 (47%), and 114 (30%) patients, respectively. The median time from access surgery to hemodialysis initiation was 69, 156, and 429 days in patients with an eGFR of <10, 10-14, and ≥15 ml/min per 1.73 m 2 , respectively ( P < 0.001). Hemodialysis was initiated within 2 years of access surgery in 298 (78%) of the patients. Catheter-free hemodialysis initiation was higher in patients with an AV graft versus an AV fistula when the eGFR was <10 ml/min per 1.73 m 2 (88% versus 43%; odds ratio [OR], 9.10 [95% confidence interval, 2.74 to 26.4]) and when the eGFR was 10-14 ml/min per 1.73 m 2 (88% versus 54%; OR, 6.05 [2.35 to 15.0]) but similar when the eGFR was ≥15 ml/min per 1.73 m 2 (90% versus 75%; OR, 3.00 [0.48 to 34.9]). Patients undergoing an AV fistula were more likely to undergo an angioplasty (11% versus 0%, P < 0.001), surgical access revision (26% versus 8%, P < 0.001), a second access placement (16% versus 6%, P = 0.02), and a catheter insertion (32% versus 11%, P < 0.001). CONCLUSIONS: Among patients with CKD undergoing vascular access surgery when their eGFR was <15 ml/min per 1.73 m 2 , catheter use at dialysis initiation was much less likely when an AV graft, rather than an AV fistula, was placed.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Allon M, Al-Balas A, Young CJ, et al. Predialysis Vascular Access Placement and Catheter Use at Hemodialysis Initiation. Clin J Am Soc Nephrol. 2023. PMID: 37843844. doi:10.2215/CJN.0000000000000317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。